XOMA Reports Second Quarter 2021 Financial Results and Highlights Recent Operational Events
Added six assets to its portfolio of potential milestone and royalty assets in 2021
Company earned $0.5 million milestone as Janssen asset entered Phase 3 development
NIS793 in combination with standard of care chemotherapy was granted Orphan Drug Designation…
